Month: September 2022
Pulsed electromagnetic fields dosing impacts postoperative pain in breast reduction patients
2015 Background Pulsed electromagnetic fields (PEMF) reduce postoperative pain and narcotic requirements in breast augmentation, reduction, and reconstruction patients. PEMF enhances both calmodulin-dependent nitric oxide and/or cyclic guanosine monophosphate signaling and phosphodiesterase activity, which blocks cyclic…
New clinical trial using Bemer: Investigation of PEMF Therapy for Female Patients With IC/BPS
September 2022: PEMF clinical trials Brief Summary: The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug),…
Clinical trial beginning April 2022: Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
Brief Summary: Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain and improves function in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA) and if…
Clinical trial for PEMF for chronic wounds (ongoing, August 2022)
AUGUST 2022 Detailed Description: The goal of the three-arm trial is to employ application of pulsed electromagnetic fields (PEMF) directly over chronic wounds combined with…
24 Prevalence, Usage, and Perceptions of Pulsed Electromagnetic Field Therapy (PEMF) in the Equine Industry
March 2022 Abstract The use of alternative therapies in the equine industry is increasing in popularity and spans manual manipulation to more progressive forms of…